FDA Approves New Version Of Glaxosmithkline Drug Lamictal

Triangle Business Journal -- The U.S. Food and Drug Administration has approved a pill version of the GlaxoSmithKline drug Lamictal that disintegrates on the tongue, the world’s second largest drug maker said Monday.